Nothing Special   »   [go: up one dir, main page]

ATE223897T1 - 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe - Google Patents

4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe

Info

Publication number
ATE223897T1
ATE223897T1 AT96924023T AT96924023T ATE223897T1 AT E223897 T1 ATE223897 T1 AT E223897T1 AT 96924023 T AT96924023 T AT 96924023T AT 96924023 T AT96924023 T AT 96924023T AT E223897 T1 ATE223897 T1 AT E223897T1
Authority
AT
Austria
Prior art keywords
alkyl
aryl
neurothophic
tetrahydropyridines
phenylalkyl
Prior art date
Application number
AT96924023T
Other languages
English (en)
Inventor
Domenico Badone
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Alessandra Ielmini
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE223897T1 publication Critical patent/ATE223897T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT96924023T 1995-06-28 1996-06-26 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe ATE223897T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507760A FR2736053B1 (fr) 1995-06-28 1995-06-28 Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1996/000995 WO1997001536A1 (fr) 1995-06-28 1996-06-26 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines ayant une activite neurotrophique et neuroprotectrice

Publications (1)

Publication Number Publication Date
ATE223897T1 true ATE223897T1 (de) 2002-09-15

Family

ID=9480466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924023T ATE223897T1 (de) 1995-06-28 1996-06-26 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe

Country Status (30)

Country Link
US (1) US5981754A (de)
EP (2) EP1216996A3 (de)
JP (2) JP3147906B2 (de)
KR (1) KR100460581B1 (de)
CN (1) CN1153765C (de)
AT (1) ATE223897T1 (de)
AU (1) AU715090B2 (de)
BR (1) BR9608662A (de)
CA (1) CA2225746C (de)
CY (1) CY2312B1 (de)
CZ (1) CZ291075B6 (de)
DE (1) DE69623631T2 (de)
DK (1) DK0837848T3 (de)
EE (1) EE03870B1 (de)
ES (1) ES2183965T3 (de)
FR (1) FR2736053B1 (de)
HK (1) HK1014952A1 (de)
HU (1) HUP9900055A3 (de)
IL (1) IL122159A (de)
IS (1) IS1999B (de)
NO (1) NO310144B1 (de)
NZ (1) NZ312723A (de)
PL (2) PL187087B1 (de)
PT (1) PT837848E (de)
RU (1) RU2163237C2 (de)
SK (2) SK285433B6 (de)
TR (1) TR199701710T1 (de)
UA (1) UA62914C2 (de)
WO (1) WO1997001536A1 (de)
ZA (1) ZA965527B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762514B1 (fr) 1997-04-29 1999-10-22 Sanofi Sa Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
FR2771007B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771006B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
CO4980891A1 (es) * 1997-11-14 2000-11-27 Sanofi Sa Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
CA2334677A1 (en) * 1998-06-19 1999-12-23 Vincent Patrick Rocco Preparation of heteroaryl compounds
FR2803593B1 (fr) * 2000-01-06 2002-02-15 Sanofi Synthelabo Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE365162T1 (de) * 2001-04-20 2007-07-15 Sanofi Aventis Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
BR0316785A (pt) * 2002-12-16 2005-10-25 Mitsubishi Pharma Corp Derivados de 4-pirimidona-3-substituìdos
US7632950B2 (en) 2003-08-18 2009-12-15 Fujifilm Finechemicals Co., Ltd Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
JP2008504278A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
CA2589565A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
EP1768954A4 (de) 2004-06-24 2008-05-28 Incyte Corp 2-methylpropanamide und deren verwendung als pharmazeutika
CA2570637A1 (en) * 2004-06-24 2006-02-02 Wenqing Yao N-substituted piperidines and their use as pharmaceuticals
MXPA06014573A (es) * 2004-06-24 2007-03-12 Incyte Corp Compuestos amido y su uso como farmaceuticos.
US20060122197A1 (en) * 2004-08-10 2006-06-08 Wenqing Yao Amido compounds and their use as pharmaceuticals
US8110581B2 (en) * 2004-11-10 2012-02-07 Incyte Corporation Lactam compounds and their use as pharmaceuticals
JP5202954B2 (ja) * 2004-11-10 2013-06-05 インサイト・コーポレイション ラクタム化合物およびその医薬としての使用
KR20070097441A (ko) * 2004-11-18 2007-10-04 인사이트 산 디에고 인코포레이티드 11-β 하이드록실 스테로이드 데하이드로게나제 유형 1의억제제 및 이를 사용하는 방법
FR2883285B1 (fr) * 2005-03-17 2007-05-18 Sanofi Aventis Sa Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP4864342B2 (ja) * 2005-04-27 2012-02-01 北興化学工業株式会社 ビアリール化合物の製造方法
JP2009508963A (ja) * 2005-09-21 2009-03-05 インサイト・コーポレイション アミド化合物および医薬組成物としてのその使用
EP1957494A2 (de) * 2005-12-05 2008-08-20 Incyte Corporation Lactam-verbindungen und verfahren zu ihrer verwendung
WO2007084314A2 (en) * 2006-01-12 2007-07-26 Incyte Corporation MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2007089683A1 (en) * 2006-01-31 2007-08-09 Incyte Corporation Amido compounds and their use as pharmaceuticals
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
US20070208001A1 (en) * 2006-03-03 2007-09-06 Jincong Zhuo Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007130898A1 (en) * 2006-05-01 2007-11-15 Incyte Corporation TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
JP2009537564A (ja) * 2006-05-17 2009-10-29 インサイト・コーポレイション １１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
JP2011507909A (ja) 2007-12-20 2011-03-10 エンビボ ファーマシューティカルズ インコーポレイテッド 四置換ベンゼン
WO2011089072A1 (de) * 2010-01-19 2011-07-28 Bayer Cropscience Ag Verfahren zur herstellung von aryl- und heteroarylessigsäure-derivaten
WO2018195649A1 (en) * 2017-04-26 2018-11-01 Alberta Research Chemicals Inc. Substituted tetrahydropyridine derivatives as ido-1 inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098248T3 (es) * 1989-05-17 1997-05-01 Pfizer Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos.
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DE4325855A1 (de) * 1993-08-02 1995-02-09 Boehringer Ingelheim Kg Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CZ291075B6 (cs) 2002-12-11
PL192353B1 (pl) 2006-10-31
JP3147906B2 (ja) 2001-03-19
NZ312723A (en) 1999-10-28
IS1999B (is) 2005-04-15
PT837848E (pt) 2002-12-31
NO310144B1 (no) 2001-05-28
SK283707B6 (sk) 2003-12-02
CN1189154A (zh) 1998-07-29
FR2736053A1 (fr) 1997-01-03
EE9700348A (et) 1998-06-15
DE69623631D1 (en) 2002-10-17
SK285433B6 (sk) 2007-01-04
PL324216A1 (en) 1998-05-11
CN1153765C (zh) 2004-06-16
TR199701710T1 (xx) 1998-05-21
NO976079D0 (no) 1997-12-23
CY2312B1 (en) 2003-11-14
JP3302351B2 (ja) 2002-07-15
HUP9900055A3 (en) 1999-11-29
BR9608662A (pt) 1999-05-04
UA62914C2 (en) 2004-01-15
EE03870B1 (et) 2002-10-15
PL187087B1 (pl) 2004-05-31
US5981754A (en) 1999-11-09
JPH11506118A (ja) 1999-06-02
RU2163237C2 (ru) 2001-02-20
IL122159A0 (en) 1998-04-05
EP0837848B1 (de) 2002-09-11
KR100460581B1 (ko) 2005-04-14
HUP9900055A2 (hu) 1999-04-28
CZ422297A3 (cs) 1998-04-15
DK0837848T3 (da) 2003-01-06
EP0837848A1 (de) 1998-04-29
JP2001114763A (ja) 2001-04-24
IL122159A (en) 2001-06-14
ZA965527B (en) 1997-01-24
NO976079L (no) 1997-12-23
HK1014952A1 (en) 1999-10-08
AU6461996A (en) 1997-01-30
EP1216996A2 (de) 2002-06-26
ES2183965T3 (es) 2003-04-01
CA2225746A1 (en) 1997-01-16
EP1216996A3 (de) 2003-10-15
IS4641A (is) 1997-12-23
WO1997001536A1 (fr) 1997-01-16
MX9710472A (es) 1998-03-31
DE69623631T2 (de) 2003-08-07
CA2225746C (en) 2004-05-18
KR19990028431A (ko) 1999-04-15
SK178197A3 (en) 1998-07-08
AU715090B2 (en) 2000-01-13
FR2736053B1 (fr) 1997-09-19

Similar Documents

Publication Publication Date Title
ATE223897T1 (de) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe
IL115572A0 (en) Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
AU3443595A (en) Benzylpiperidine derivatives
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
NO914218L (no) Synergistiske ultrafiolettabsorberblandinger inneholdendehydroksyaryltriaziner og tetraalkylpiperidiner
FR2757056B1 (fr) Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
PT96937A (pt) Processo para a preparacao de derivados de n-(4-piperidinil) (di-hidro-benzofurano ou di-hidro-2h-benzopiran) carboxamida e de composicoes farmaceuticas que os contem
TNSN86080A1 (fr) Amides et leurs procedes de preparation
ATE110719T1 (de) Fungizide oxazolidinone.
ATE285403T1 (de) Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen
IL116387A (en) 5-acyl-1,4-dihydropyridines for control of disorders of CNS with modulating action on potassium channels certain such novel compounds and their preparation
DE69625069D1 (de) Insektizide von n-(substituiertes arylmethyl)-4-(bis (substituiertes phenyl oder pyridyl)methyl)-piperidin.
ATE115130T1 (de) Disubstituierte piperidine und pyrrolidine als anticholinergische mittel.
RS49807B (sr) 1-fenilalkil-1,2,3,6- tetrahidropiridini za tretiranje alzheimer-ovog oboljenja
RU99115083A (ru) 1-фенилалкил-1,2,3,6-тетрагидропиридины для лечения болезни альцгеймера
MX9801493A (es) Amidas del acido fluorbutenoico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0837848

Country of ref document: EP

REN Ceased due to non-payment of the annual fee